{"success":true,"data":{"pressRelease":{"id":"153734","rtpr_id":"nGNEb15qvW-20260928","ticker":"SPI","exchange":"LSE","all_tickers":["SPI"],"title":"REG-Man Group PLC : Form 8.3 - Spire Healthcare Group Plc","author":"Globe Newswire","published_at":"2026-09-28T09:13:52.085Z","article_body":"FORM 8.3\n\nPUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY \nA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE\nRule 8.3 of the Takeover Code (the “Code”)\n\n1.        KEY INFORMATION\n\n (a) Full name of discloser: Man Group PLC \n (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. \n (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Spire Healthcare Group plc \n (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: \n (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 25/09/2026 \n (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? NO \n\n2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE\n\nIf there are positions or rights to subscribe to disclose in more than one\nclass of relevant securities of the offeror or offeree named in 1(c), copy\ntable 2(a) or (b) (as appropriate) for each additional class of relevant\nsecurity.\n\n(a)      Interests and short positions in the relevant securities of the\nofferor or offeree to which the disclosure relates following the dealing (if\nany)\n\n Class of relevant security: 1p ordinary \n Interests Short positions \n Number % Number % \n (1) Relevant securities owned and/or controlled: \n (2) Cash-settled derivatives: 6,169,320 1.53 \n (3) Stock-settled derivatives (including options) and agreements to purchase/sell: \n TOTAL: 6,169,320 1.53 \n\nAll interests and all short positions should be disclosed.\n\nDetails of any open stock-settled derivative positions (including traded\noptions), or agreements to purchase or sell relevant securities, should be\ngiven on a Supplemental Form 8 (Open Positions).\n\n(b)      Rights to subscribe for new securities (including directors’\nand other employee options)\n\n Class of relevant security in relation to which subscription right exists: \n Details, including nature of the rights concerned and relevant percentages: \n\n3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE\n\nWhere there have been dealings in more than one class of relevant securities\nof the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as\nappropriate) for each additional class of relevant security dealt in.\n\nThe currency of all prices and other monetary amounts should be stated.\n\n(a)        Purchases and sales\n\n Class of relevant security Purchase/sale Number of securities Price per unit \n\n(b)        Cash-settled derivative transactions\n\n Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit \n 1p ordinary Equity swap Reducing a long position 240 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 34 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 154 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 640 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 93 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 412 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 97 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 13 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 62 2.4550 GBP \n\n        \n(c)        Stock-settled derivative transactions (including options)\n\n(i)        Writing, selling, purchasing or varying\n\n Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit \n\n(ii)        Exercise\n\n Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit \n\n(d)        Other dealings (including subscribing for new securities)\n\n Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) \n\n4.        OTHER INFORMATION\n\n(a)        Indemnity and other dealing arrangements\n\n Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: \n None \n\n(b)        Agreements, arrangements or understandings relating to\noptions or derivatives\n\n Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: \n None \n\n(c)        Attachments\n\n Is a Supplemental Form 8 (Open Positions) attached? NO \n\n\n\n Date of disclosure: 28/09/2026 \n Contact name: Molly Childs \n Telephone number: +44 20 7144 3714 \n\nPublic disclosures under Rule 8 of the Code must be made to a Regulatory\nInformation Service.\n\nThe Panel’s Market Surveillance Unit is available for consultation in\nrelation to the Code’s disclosure requirements on +44 (0)20 7638 0129.\n\nThe Code can be viewed on the Panel’s website at\nwww.thetakeoverpanel.org.uk.","article_body_html":"","raw_payload":{"data":{"id":"nGNEb15qvW-20260928","title":"REG-Man Group PLC : Form 8.3 - Spire Healthcare Group Plc","author":"Globe Newswire","ticker":"SPI","created":"2026-09-28T09:13:52.085Z","tickers":["SPI"],"exchange":"LSE","article_body":"FORM 8.3\n\nPUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY \nA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE\nRule 8.3 of the Takeover Code (the “Code”)\n\n1.        KEY INFORMATION\n\n (a) Full name of discloser: Man Group PLC \n (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. \n (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Spire Healthcare Group plc \n (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: \n (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 25/09/2026 \n (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? NO \n\n2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE\n\nIf there are positions or rights to subscribe to disclose in more than one\nclass of relevant securities of the offeror or offeree named in 1(c), copy\ntable 2(a) or (b) (as appropriate) for each additional class of relevant\nsecurity.\n\n(a)      Interests and short positions in the relevant securities of the\nofferor or offeree to which the disclosure relates following the dealing (if\nany)\n\n Class of relevant security: 1p ordinary \n Interests Short positions \n Number % Number % \n (1) Relevant securities owned and/or controlled: \n (2) Cash-settled derivatives: 6,169,320 1.53 \n (3) Stock-settled derivatives (including options) and agreements to purchase/sell: \n TOTAL: 6,169,320 1.53 \n\nAll interests and all short positions should be disclosed.\n\nDetails of any open stock-settled derivative positions (including traded\noptions), or agreements to purchase or sell relevant securities, should be\ngiven on a Supplemental Form 8 (Open Positions).\n\n(b)      Rights to subscribe for new securities (including directors’\nand other employee options)\n\n Class of relevant security in relation to which subscription right exists: \n Details, including nature of the rights concerned and relevant percentages: \n\n3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE\n\nWhere there have been dealings in more than one class of relevant securities\nof the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as\nappropriate) for each additional class of relevant security dealt in.\n\nThe currency of all prices and other monetary amounts should be stated.\n\n(a)        Purchases and sales\n\n Class of relevant security Purchase/sale Number of securities Price per unit \n\n(b)        Cash-settled derivative transactions\n\n Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit \n 1p ordinary Equity swap Reducing a long position 240 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 34 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 154 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 640 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 93 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 412 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 97 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 13 2.4550 GBP \n 1p ordinary Equity swap Reducing a long position 62 2.4550 GBP \n\n        \n(c)        Stock-settled derivative transactions (including options)\n\n(i)        Writing, selling, purchasing or varying\n\n Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit \n\n(ii)        Exercise\n\n Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit \n\n(d)        Other dealings (including subscribing for new securities)\n\n Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) \n\n4.        OTHER INFORMATION\n\n(a)        Indemnity and other dealing arrangements\n\n Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: \n None \n\n(b)        Agreements, arrangements or understandings relating to\noptions or derivatives\n\n Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: \n None \n\n(c)        Attachments\n\n Is a Supplemental Form 8 (Open Positions) attached? NO \n\n\n\n Date of disclosure: 28/09/2026 \n Contact name: Molly Childs \n Telephone number: +44 20 7144 3714 \n\nPublic disclosures under Rule 8 of the Code must be made to a Regulatory\nInformation Service.\n\nThe Panel’s Market Surveillance Unit is available for consultation in\nrelation to the Code’s disclosure requirements on +44 (0)20 7638 0129.\n\nThe Code can be viewed on the Panel’s website at\nwww.thetakeoverpanel.org.uk."},"type":"article","timestamp":"2026-09-28T09:13:52.193291157Z","server_sent_at_ms":1790586832193},"received_at":"2026-09-28T09:13:52.260Z","source_url":null},"analysis":{"id":"142526","press_release_id":"153734","analysis_json":{"industry":{"label":"Health Care Providers & Services","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Man Group PLC filed a Rule 8.3 Takeover Code disclosure revealing a 1.53% cash-settled derivative position (6,169,320 shares) in Spire Healthcare Group plc as of 25 September 2026.\n\nThe filing shows only de minimis dealing: a series of equity swap transactions reducing the long position by small increments, all at 2.4550 GBP per unit.\n\nThis is routine regulatory boilerplate required of 1%+ holders during an offer period; it contains no new information about the offer itself or Spire's fundamentals.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine Rule 8.3 filing during offer period -- aggregate with other 8.3 disclosures only if tracking stake accumulation in Spire."},"keyFigures":{"customDimensions":{"position_date":"25/09/2026","swap_reduction_price":"2.4550 GBP","derivative_position_pct":"1.53%","derivative_position_shares":6169320}},"namedEntities":{"people":[{"name":"Molly Childs","role":"disclosure contact"}],"products":[],"companies":[{"name":"Man Group PLC","ticker":"MAN.L","relationship":"discloser/fund manager with 1%+ derivative position"},{"name":"Spire Healthcare Group plc","ticker":"SPI","relationship":"offeree company subject of disclosure"}],"dollarAmounts":[{"amount":"2.4550 GBP","context":"price per unit of equity swap transactions reducing long position"}]},"materialImpact":{"score":1,"reasoning":"Routine UK Takeover Code Rule 8.3 position disclosure by Man Group regarding its cash-settled derivative exposure (1.53%) in Spire Healthcare, with only minor swap reductions. Standard regulatory filing boilerplate with no new information about the takeover or the company."},"tickerRelevance":{"others":[{"ticker":"MAN.L","relevance":"discloser making the Rule 8.3 position disclosure"}],"primary":"SPI"},"globalImportance":8,"audienceRelevance":12,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"routine-takeover-code-disclosure","issuerAuthored":false,"regulatoryFiling":true}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Man Group PLC filed a Rule 8.3 Takeover Code disclosure revealing a 1.53% cash-settled derivative position (6,169,320 shares) in Spire Healthcare Group plc as of 25 September 2026.\n\nThe filing shows only de minimis dealing: a series of equity swap transactions reducing the long position by small increments, all at 2.4550 GBP per unit.\n\nThis is routine regulatory boilerplate required of 1%+ holders during an offer period; it contains no new information about the offer itself or Spire's fundamentals.","key_figures":{"customDimensions":{"position_date":"25/09/2026","swap_reduction_price":"2.4550 GBP","derivative_position_pct":"1.53%","derivative_position_shares":6169320}},"named_entities":{"people":[{"name":"Molly Childs","role":"disclosure contact"}],"products":[],"companies":[{"name":"Man Group PLC","ticker":"MAN.L","relationship":"discloser/fund manager with 1%+ derivative position"},{"name":"Spire Healthcare Group plc","ticker":"SPI","relationship":"offeree company subject of disclosure"}],"dollarAmounts":[{"amount":"2.4550 GBP","context":"price per unit of equity swap transactions reducing long position"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-28T09:13:58.836Z","global_importance":8,"audience_relevance":12,"importance_components":{"tickerTier":"small-cap","eventGravity":"routine-takeover-code-disclosure","issuerAuthored":false,"regulatoryFiling":true}},"durationMs":null,"modelName":"glm-5.3-flashx"}}